Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000289614 | SCV000470331 | uncertain significance | Congenital long QT syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001506175 | SCV001711091 | likely benign | Long QT syndrome | 2022-08-28 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002446614 | SCV002753529 | likely benign | Cardiovascular phenotype | 2019-08-27 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV003437129 | SCV004164295 | likely benign | not provided | 2022-08-01 | criteria provided, single submitter | clinical testing | AKAP9: BP4, BP7 |